The preanalytical phase in the era of high-throughput genetic testing. What the future holds

Diagnosis

Volumn 6, Issue 1, 2019, Pages 73-74

  Lippi, Giuseppe ^a   Simundic, Ana Maria ^b  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

^b Croatian Academy of Medical Sciences   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL DECISION MAKING; CLINICAL LABORATORY; DIAGNOSTIC ERROR; DIAGNOSTIC PROCEDURE; EDITORIAL; EXOSOME; GENETIC PROCEDURES; GENETIC SCREENING; HEALTH CARE COST; HEALTH CARE SYSTEM; HIGH THROUGHPUT SCREENING; HOSPITAL ADMINISTRATOR; HUMAN; IMMUNOCHEMISTRY; LABORATORY; LABORATORY PERSONNEL; LABORATORY TEST; LIQUID BIOPSY; PRE-ANALYTICAL PHASE; PRIORITY JOURNAL; PROTEIN ELECTROPHORESIS; SOMATIC MUTATION;

EID: 85062051467     PISSN: 21948011     EISSN: 2194802X     Source Type: Journal    
DOI: 10.1515/dx-2018-0022     Document Type: Editorial

References (14)

1. Lippi G, Guidi GC, Plebani M. One hundred years of laboratory testing and patient safety. Clin Chem Lab Med 2007;45:797-8.
2. Lippi G, Plebani M. Laboratory medicine does matter in science (and medicine). yet many seem to ignore it. Clin Chem Lab Med 2015;53:1655-6.
3. Lippi G, Simundic AM. Laboratory networking and sample quality: a still relevant issue for patient safety. Clin Chem Lab Med 2012;50:1703-5.
4. Lippi G, Plebani M. Laboratory economics. Risk or opportunity? Clin Chem Lab Med 2016;54:1701-3.
5. Simundic AM, Lippi G. Preanalytical phase - a continuous challenge for laboratory professionals. Biochem Med (Zagreb) 2012;22:145-9.
6. Lippi G, Simundic AM. The EFLM strategy for harmonization of the preanalytical phase. Clin Chem Lab Med 2017 Jun 3. doi: 10.1515/cclm-2017-0277. [Epub ahead of print].
7. Ravine D, Suthers G. Quality standards and samples in genetic testing. J Clin Pathol 2012;65:389-93.
8. Sehn JK, Spencer DH, Pfeifer JD, Bredemeyer AJ, Cottrell CE, Abel HJ, et al. Occult specimen contamination in routine clinical nextgeneration sequencing testing. Am J Clin Pathol 2015;144:667-74.
9. Domínguez-Vigil IG, Moreno-Martínez AK, Wang JY, Roehrl MH, Barrera-Saldaña HA. The dawn of the liquid biopsy in the fight against cancer. Oncotarget 2017;9:2912-22.
10. Jung M, Klotzek S, Lewandowski M, Fleischhacker M, Jung K. Changes in concentration of DNA in serum and plasma during storage of blood samples. Clin Chem 2003;49:1028-9.
11. Nikolaev S, Lemmens L, Koessler T, Blouin JL, Nouspikel T. Circulating tumoral DNA: preanalytical validation and quality control in a diagnostic laboratory. Anal Biochem 2018;542:34-9.
12. Fernando MR, Jiang C, Krzyzanowski GD, Ryan WL. New evidence that a large proportion of human blood plasma cell-free DNA is localized in exosomes. PLoS One 2017;12:e0183915.
13. Pérez-Barrios C, Nieto-Alcolado I, Torrente M, Jiménez- Sánchez C, Calvo V, Gutierrez-Sanz L, et al. Comparison of methods for circulating cell-free DNA isolation using blood from cancer patients: impact on biomarker testing. Transl Lung Cancer Res 2016;5:665-72.
14. Sciacovelli L, Lippi G, Sumarac Z, West J, Garcia Del Pino Castro I, Furtado Vieira K, et al. Quality Indicators in Laboratory Medicine: the status of the progress of IFCC Working Group "Laboratory Errors and Patient Safety" project. Clin Chem Lab Med 2017;55:348-57.